CINDA INTL HLDG (00111) purchases bonds and notes
Xinda International Holdings (00111) announced that on September 4, 2026 (after trading hours), the company purchased off-market a note from Socit Gnrale in the amount of 6 million US dollars (equivalent to approximately 46.8 million Hong Kong dollars) at a cost of about 6.01 million US dollars (equivalent to approximately 46.88 million Hong Kong dollars).
CINDA INTL HLDG (00111) announced that on September 4, 2026 (after trading hours), the company purchased a total of USD 6 million (equivalent to approximately HKD 46.8 million) of BNP Paribas notes in the over-the-counter market, for a total consideration of approximately USD 6.01 million (equivalent to approximately HKD 46.88 million).
On September 4, 2026 (after trading hours), the company acquired a total principal amount of USD 1.245 million (equivalent to approximately HKD 9.71 million) of China Greatwall Technology Group bonds in the over-the-counter market, for a total consideration of approximately USD 1.13 million (equivalent to approximately HKD 8.81 million).
On September 4, 2026 (after trading hours), the company purchased a total amount of USD 6 million (equivalent to approximately HKD 46.8 million) of HSBC notes in the over-the-counter market, for a total consideration of approximately USD 6.12 million (equivalent to approximately HKD 47.74 million).
Related Articles
TIMES CHINA (01233) reported a cumulative contract sales amount of approximately 2.237 billion yuan in the first eight months, a year-on-year decrease of 38.41%.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-1179 Injection has obtained the Clinical Trial Approval Notification.
Nanchang Jiahui, a shareholder of Jiangxi Guoke Defence Group (688543.SH), intends to reduce its holdings by no more than 3%.
TIMES CHINA (01233) reported a cumulative contract sales amount of approximately 2.237 billion yuan in the first eight months, a year-on-year decrease of 38.41%.
Jiangsu Hengrui Pharmaceuticals (01276): SHR-1179 Injection has obtained the Clinical Trial Approval Notification.
Nanchang Jiahui, a shareholder of Jiangxi Guoke Defence Group (688543.SH), intends to reduce its holdings by no more than 3%.
RECOMMEND
